FDA Medical devices recall ·

Pacific Hemostasis Thromboplastin-D, 4 ml recall

Recall number
Z-1502-2025
Date
(initiated March 6, 2025)
Company / brand
Fisher Diagnostics
8365 Valley Pike, Middletown, VA, United States
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
4,387 units
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Pacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time test and factor assays.

Why was it recalled?

The incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Catalog No. 100356; UDI: 00845275000542719170261130100356; Lot No. 719170; Exp. Date 11/30/26.

Distribution

US Distribution to: PA and OUS Foreign country of: United Arab Emirates.

States: Pennsylvania

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-1502-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.